Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Biostatistics: Overview01:20

Biostatistics: Overview

Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solving the Hubbard model with neural quantum states.

Nature communications·2026
Same author

SERS Facemask for Rapid and Portable Sensing Mycobacterium Tuberculosis Antigens for TB Screening.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Letter: Predictors and Outcomes of Pulmonary Embolism After Coronary Artery Bypass Grafting.

Angiology·2026
Same author

Semantic-Decoupled and Knowledge-Shared Probabilistic Mapping Network for Multi-Grained Cross-Modal Retrieval.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Aberrant expression of GBP5 in tumor-infiltrating immune cells as an onco-immunological biomarker in pan-cancer.

Discover oncology·2026
Same author

MethylCurate: Tool for Dataset Curation and Epigenetic Aging Clock Evaluation.

bioRxiv : the preprint server for biology·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: May 19, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Knowledge-guided Bayesian biclustering model for omics data with noisy graphs.

Qiyiwen Zhang1, Wenrui Li2, Suprateek Kundu3

  • 1Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States.

Biometrics
|May 18, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a novel Bayesian biclustering method to improve disease subtyping by integrating noisy biological network data. The approach effectively handles false positive and false negative edges for more accurate biological insights.

Keywords:
Bayesian modelMCMCbiclusteringdenoised networkknowledge-guided

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

Related Experiment Videos

Last Updated: May 19, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Systems Biology

Background:

  • High-dimensional omics data analysis presents challenges in biomedical research.
  • Disease subtyping is crucial for personalized medicine, diagnosis, and treatment.
  • Biclustering is a key statistical method for disease subtyping.

Purpose of the Study:

  • To develop a robust biclustering method that integrates noisy biological graph knowledge.
  • To address limitations of existing methods in handling false positive and false negative graph edges.
  • To enhance the accuracy and interpretability of biclustering for disease subtyping.

Main Methods:

  • A Bayesian denoising knowledge-guided biclustering approach is proposed.
  • Multiple biological graphs are integrated and de-noised by modeling false positive/negative errors.
  • A Markov chain Monte Carlo algorithm is utilized for bicluster estimation.

Main Results:

  • The proposed method effectively handles noisy biological graphs.
  • Simulations and real-world data analyses demonstrate superior performance.
  • Accurate biclusters were identified from gene expression and proteomics data.

Conclusions:

  • The Bayesian denoising method offers a significant advancement in graph-guided biclustering.
  • This approach enhances disease subtyping by robustly integrating biological network information.
  • The method provides valuable biological insights for complex diseases like Alzheimer's.